These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28665213)

  • 21. European Union support of gene therapy research: a success story.
    Gancberg D; Kessler C; Hoeveler A; Draghia-Akli R
    Mol Ther; 2012 Dec; 20(12):2191-3. PubMed ID: 23201611
    [No Abstract]   [Full Text] [Related]  

  • 22. New era in gene therapy: end of the beginning.
    Morishita R
    Expert Opin Biol Ther; 2015 Mar; 15(3):309-10. PubMed ID: 25686245
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene therapy for diseases of the cornea - a review.
    Williams KA; Coster DJ
    Clin Exp Ophthalmol; 2010 Mar; 38(2):93-103. PubMed ID: 19958372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive resource on EU regulatory information for investigators in gene therapy clinical research and advanced therapy medicinal products.
    Cohen-Haguenauer O
    Hum Gene Ther; 2013 Jan; 24(1):12-8. PubMed ID: 23339285
    [No Abstract]   [Full Text] [Related]  

  • 25. A brief account of viral vectors and their promise for gene therapy.
    Finer M; Glorioso J
    Gene Ther; 2017 Jan; 24(1):1-2. PubMed ID: 28123184
    [No Abstract]   [Full Text] [Related]  

  • 26. What strategy should France implement for H2020?
    Dhainaut JF; Diebolt V; Pouletty-Lefèbvre B; ; Baker A; Bassompierre F; Borel T; Braunstein D; Demotes J; François B; Huet S; Micallef J; Misse C; Molon A; Rascol O; Ravoire S; Schwartz B; Donne N; Donne N; Fusaï G; Pouletty P; Vicaut E
    Therapie; 2015; 70(1):95-109. PubMed ID: 25747841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy and gene transfer approaches to prevent or treat chronic virus infections.
    Berkout B; Ertl HC; Weinberg MS
    Adv Exp Med Biol; 2015; 848():v-vii. PubMed ID: 26034787
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union: How Are the Product Pipeline and Regulatory Framework Evolving?
    Boráň T; Menezes-Ferreira M; Reischl I; Celis P; Ferry N; Gänsbacher B; Krafft H; Lipucci di Paola M; Sladowski D; Salmikangas P
    Hum Gene Ther Clin Dev; 2017 Sep; 28(3):126-135. PubMed ID: 28510497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status and recent advances of gene therapy in hematological diseases.
    Yamamoto M; Tani K
    Int J Hematol; 2016 Jul; 104(1):4-5. PubMed ID: 27250344
    [No Abstract]   [Full Text] [Related]  

  • 30. Human gene therapy: novel approaches to improve the current gene delivery systems.
    Cucchiarini M
    Discov Med; 2016 Jun; 21(118):495-506. PubMed ID: 27448786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Basis of gene therapy: principles and state of development].
    Hallek M; Buening H; Ried M; Hacker U; Kurzeder C; Wendtner CM
    Internist (Berl); 2001 Oct; 42(10):1306-8, 1311-3. PubMed ID: 11688149
    [No Abstract]   [Full Text] [Related]  

  • 32. New Japanese Regulatory Frameworks for Clinical Research and Marketing Authorization of Gene Therapy and Cellular Therapy Products.
    Nagai S; Ozawa K
    Curr Gene Ther; 2017; 17(1):17-28. PubMed ID: 28382858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preparation of the Eighth Framework Programme of the European Union--Health Priority. European Commission organizes proposal of aims in biomedical research prospecting to 2020].
    Kinkorová J
    Cas Lek Cesk; 2011; 150(9):502-5. PubMed ID: 22132619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiac and vascular gene therapy in cardiology. Current status and future prospects].
    Kalka C; Isner JM
    Internist (Berl); 2002 Apr; 43 Suppl 1():S66-75. PubMed ID: 11993001
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthetic nucleic acid nanomedicines: A Chinese perspective.
    Yu H; Huang R; Nie Y
    J Gene Med; 2019 Jul; 21(7):e3111. PubMed ID: 31359562
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulatory structures for gene therapy medicinal products in the European Union.
    Klug B; Celis P; Carr M; Reinhardt J
    Methods Enzymol; 2012; 507():337-54. PubMed ID: 22365782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene and Cell Doping: The New Frontier - Beyond Myth or Reality.
    Neuberger EWI; Simon P
    Med Sport Sci; 2017; 62():91-106. PubMed ID: 28578328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The European hospital exemption clause-new option for gene therapy?
    Buchholz CJ; Sanzenbacher R; Schüle S
    Hum Gene Ther; 2012 Jan; 23(1):7-12. PubMed ID: 22247961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus document on European brain research.
    Olesen J; Baker MG; Freund T; di Luca M; Mendlewicz J; Ragan I; Westphal M
    J Neurol Neurosurg Psychiatry; 2006 Aug; 77 Suppl 1(Suppl 1):i1-49. PubMed ID: 16845120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A harmonized and efficient clinical research environment would benefit patients and enhance European competitiveness. Commentary.
    Amato A; Aringhieri E; Boccia S; Buccella F; Gorini B; Gramaglia D; Masetti R; Rossi P; Pelicci PG
    Ann Ist Super Sanita; 2017; 53(2):104-107. PubMed ID: 28617255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.